fbpx Skip to main content

BioCommunique Article

The company is providing their turn-key solution to employers as they prepare to bring employees back to workplaces.

StemExpress Offering Biocom Members Preferred Pricing on COVID-19 Testing

  • 2020-05-13T19:00:00.000+0000
  • California
  • Author: StemExpress

In response to the pandemic of COVID-19 throughout our nation, StemExpress is offering COVID-19 testing to its biotechnology partners and life science companies across the country.

StemExpress is a certified woman-owned biotechnology company headquartered in Folsom, California, with additional sites in San Diego, Boston, Philadelphia, Rockville, Raleigh, and a new location in San Francisco opening in June 2020.

The company’s model offers a complete turn-key solution to assist companies with back to work initiatives by screening employees through COVID-19 testing for active infection through molecular testing (RT-PCR) or potential previous exposure/immunity through antibody testing. All tests are authorized for use by the FDA and testing is run in the StemExpress high-complexity CLIA laboratory in Folsom, California.

As employers are planning their back to work strategy, StemExpress is working to build a testing model that fits specific needs. The company handles registration of employees, sample collection, testing, and results reporting. On-site testing in small or large groups is available through indoor facilities, drive-through models, or pop-up locations. Their collection staff are licensed, trained, and provide a professional and seamless experience for participants.

StemExpress is offering preferred pricing for Biocom members. If you are interested in learning more about workforce testing for your organization, visit stemexpress.com/covid-19-testing, email StemExpress, or reach out to their VP, Business Development, Matt Phillips at (530) 303-3831 or by email.